Paragonix Technologies names Leonard A. R. Golding as CMO
Monday, June 25, 2012
Paragonix Technologies, a medical device company of Cambridge, Mass., has appointed Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, as chief medical officer.
Golding will be responsible for all clinical development activities related to the Paragonix’s Sherpa Cardiac Transport System. He will also immediately assume the position of chairman for the Paragonix clinical advisory board.
Golding currently serves on staff in the department of biomedical engineering at Cleveland Clinic and has a secondary appointment in the department of thoracic and cardiovascular surgery at Cleveland Clinic’s main campus. He is also the project director for the NIH-funded development of a unique total artificial heart blood pump. In addition, Golding is an international speaker and has authored over 210 peer-reviewed publications.